ConductScience.org, home

Paper · 168488

Predominantly T-cell infiltrate in rheumatoid synovial membranes.

Van Boxel JA and 1 other. N Engl J Med, 1975. Cited by 369 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Predominantly T-cell infiltrate in rheumatoid synovial membranes. Papers, record 168488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/168488

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predominantly T-cell infiltrate in rheumatoid synovial membranes.
PubMed
Journal
N Engl J Med
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
369
iCite
Relative citation ratio, by iCite
8.33
iCite
Revised in PubMed
2011-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Boxel JAJ A
2Paget SAS A

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Synovial MembraneMajor topic
T-LymphocytesMajor topic
Adolescent
Binding Sites, Antibody
Cell Separation
Complement C3
Deoxyribonucleases
Female
Humans
Immune Adherence Reaction
Lymphocytes
Male
Microbial Collagenase
Middle Aged
Receptors, Antigen, B-Cell
Synovitis

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by114

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 369 citations.

PMIDTitleJournalYearIn PapersSource
41,613,106Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.Front Immunol2025https://conductscience.org/library/papers/41613106PubMed
38,336,809Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis.Arthritis Res Ther2024https://conductscience.org/library/papers/38336809PubMed
37,893,571Rheumatoid Arthritis Has Won the Battle but Not the War: How Many Joints Will We Save Tomorrow?Medicina (Kaunas)2023https://conductscience.org/library/papers/37893571PubMed
35,210,510Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis.Sci Rep2022https://conductscience.org/library/papers/35210510PubMed
34,394,100Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis.Front Immunol2021https://conductscience.org/library/papers/34394100PubMed
33,680,781Incisionless Synovium and Bone Biopsy of a Painful Total Knee Arthroplasty.Arthrosc Tech2021https://conductscience.org/library/papers/33680781PubMed
33,504,785Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation.Nat Commun2021https://conductscience.org/library/papers/33504785PubMed
33,229,974Rheumatology in the era of precision medicine: synovial tissue molecular patterns and treatment response in rheumatoid arthritis.Curr Opin Rheumatol2021https://conductscience.org/library/papers/33229974PubMed
31,938,116Knockdown of LSD1 ameliorates the severity of rheumatoid arthritis and decreases the function of CD4 T cells in mouse models.Int J Clin Exp Pathol2018https://conductscience.org/library/papers/31938116PubMed
30,765,202IL-17 and limits of success.Cell Immunol2019https://conductscience.org/library/papers/30765202PubMed

1 to 10 of 114

See all 114 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/168488

GET https://conductscience.org/api/papers/v1/168488/cited_by?page=2